文献リスト

1) 日本透析医学会統計調査委員会. わが国の慢性透析療法の現況(2009年12月31日現在). 東京, 日本透析医会, 2010

2) Silverberg DS, Wexler D, Blum M, et al. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol. 2003; 60: S93-S102

3) Iaina A, Silverberg DS, Wexler D. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome. Nat Clin Pract Cardiovasc Med. 2005; 2: 95-100

4) Coca SG, Krumholz HM, Garg AX, et al. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006; 296: 1377-84

5) Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010; 31: 703-11C

6) Davenport A, Anker SD, Mebazaa A, et al. ADQI 7: the clinical management of the cardio-renal syndromes: work group statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010; 25: 2077-89

7) Newsome BB, Warnock DG, McClellan WM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008; 168: 609-16

8) Parikh CR, Coca SG, Wang YF, et al. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med. 2008; 168: 987-95

9) Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the Eur Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008; 10: 933-89

10) Heywood JT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J Card Fail. 2007; 13: 422-30

11) Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113: 671-8

12) Aukrust P, Gullestad L, Ueland T, et al. Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications. Ann Med. 2005; 37: 74-85

13) 慢性心不全治療ガイドライン(2005年度改訂版). 循環器病の診断と治療に関するガイドライン. 日本循環器学会合同研究班報. 2005

14) Jessup M, Abraham WT, Casey DE, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 119: 1977-2016

15) Hoste EA, Kellum JA. Acute kidney injury: epidemiology and diagnostic criteria. Curr Opin Criti Care. 2006; 12: 531-7

16) Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52: 1527-39

17) 急性心不全治療ガイドライン(2006年度改訂版). 循環器病の診断と治療に関するガイドライン. 日本循環器学会合同研究班報. 2006

18) Kazory A, Ross EA. Contemporary trends in the pharmacological and extracorporeal management of heart failure-A nephrologic perspective. Circulation. 2008; 117: 975-83

19) Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease-A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003; 108: 2154-69

20) Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-305

21) Shamseddin MK, Parfrey PS. Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol. 2009; 5: 641-9

22) Ueda S, Yamagishi S, Okuda S. New pathways to renal damage: role of ADMA in retarding renal disease progression. J Nephrol. 2010; 23: 377-86

23) Nakagawa N, Takahashi F, Chinda J, et al. A newly estimated glomerular filtration rate is independently associated with arterial stiffness in Japanese patients. Hypertens Res. 2008; 31: 193-201

24) Bagshaw SM, Lapinsky S, Dial S, et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 2009; 35: 871-81

25) Iwanaga Y, Miyazaki S. Heart failure, chronic kidney disease, and biomarkers - an integrated viewpoint. Circ J. 2010; 74: 1274-82

26) Porapakkham P, Zimmet H, Billah B, et al. B-type natriuretic peptide-guided heart failure therapy a meta-analysis. Arch Intern Med. 2010; 170: 507-14

27) Berger R, Moertl D, Peter S, et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure. A 3-Arm, Prospective, Randomized Pilot Study. J Am Coll Cardiol. 2010; 55: 645-53

28) van Kimmenade RRJ, Januzzi JL, Bakker JA, et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol. 2009; 53: 884-90

29) Tagore R, Ling LH, Yang H, et al. Natriuretic peptides in chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1644-51

30) Gardner RS, Chong KS, O'Meara E, et al. Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure. Eur Heart J. 2007; 28: 3027-33

31) Ostermann M, Alvarez G, Sharpe MD, et al. Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract. 2007; 107: C70-6

32) Thomson MR, Nappi JM, Dunn SP, et al. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010; 16: 188-93

33) Hollenberg SM. Vasodilators in acute heart failure. Heart Fail Rev. 2007; 12: 143-7

34) Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension. J Hypertens. 2007; 25: 1105-87

35) Lee CY, Burnett JC. Natriuretic peptides and therapeutic applications. Heart Fail Rev. 2007; 12: 131-42

36) Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005; 111: 1487-91

37) Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007; 49: 675-83

38) Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, et al. Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan-A Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J. 2009; 73: 1901-8

39) Drüeke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006; 355: 2071-84

40) Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006; 355: 2085-98

41) Phrommintikul A, Haas SJ, Elsik M, et al. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007; 369: 381-8

42) 日本透析医学会. 2008 年版｢慢性腎臓病における腎性貧血治療ガイドライン｣. 日本透析医学会雑誌. 2008; 41: 661-716

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp